Diagnostic and therapeutic potential of exosomes in Alzheimer's disease

T Soares Martins, D Trindade, M Vaz… - Journal of …, 2021 - Wiley Online Library
Exosomes are small extracellular vesicles released by almost all cell types in physiological
and pathological conditions. The exosomal potential to unravel disease mechanisms, or to …

Modifications and trafficking of APP in the pathogenesis of Alzheimer's disease

X Wang, X Zhou, G Li, Y Zhang, Y Wu… - Frontiers in molecular …, 2017 - frontiersin.org
Alzheimer's disease (AD), the most common neurodegenerative disorder, is the leading
cause of dementia. Neuritic plaque, one of the major characteristics of AD neuropathology …

Impact of cytokines and chemokines on Alzheimer's disease neuropathological hallmarks

C Domingues, O AB da Cruz e Silva… - Current Alzheimer …, 2017 - ingentaconnect.com
Background: Alzheimer's disease (AD) is the most common neurodegenerative disorder,
neuropathologically characterized by aggregates of β-amyloid peptides, which deposit as …

Molecular insight into the therapeutic promise of flavonoids against Alzheimer's disease

MS Uddin, MT Kabir, K Niaz, P Jeandet, C Clément… - Molecules, 2020 - mdpi.com
Alzheimer's disease (AD) is one of the utmost chronic neurodegenerative disorders, which is
characterized from a neuropathological point of view by the aggregates of amyloid beta (Aβ) …

Regulation of mitochondrial functions by protein phosphorylation and dephosphorylation

S Lim, KR Smith, STS Lim, R Tian, J Lu, M Tan - Cell & bioscience, 2016 - Springer
The mitochondria are double membrane-bound organelles found in most eukaryotic cells.
They generate most of the cell's energy supply of adenosine triphosphate (ATP). Protein …

Role of post‐translational modifications in Alzheimer's disease

M Ramesh, P Gopinath, T Govindaraju - ChemBioChem, 2020 - Wiley Online Library
The global burden of Alzheimer's disease (AD) is growing. Valiant efforts to develop clinical
candidates for treatment have continuously met with failure. Currently available palliative …

Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease

N Jin, H Zhu, X Liang, W Huang, Q Xie, P Xiao… - Experimental …, 2017 - Elsevier
Accumulating evidences show that selenium dietary intake is inversely associated with the
mortality of Alzheimer's disease (AD). Sodium selenate has been reported to reduce …

Pharmacological relevance of CDK inhibitors in Alzheimer's disease

N Malhotra, R Gupta, P Kumar - Neurochemistry International, 2021 - Elsevier
Evidence suggests that cell cycle activation plays a role in the pathophysiology of
neurodegenerative diseases. Alzheimer's disease is a progressive, terminal …

ABC transporters are key players in Alzheimer's disease

CD Pereira, F Martins, J Wiltfang… - Journal of …, 2017 - journals.sagepub.com
Human ATP-binding cassette (ABC) transporters mediate a critical function in the cell,
namely the transport of molecules across lipid membranes. Associated to their ubiquitous …

Modulation of disordered proteins with a focus on neurodegenerative diseases and other pathologies

AHS Martinelli, FC Lopes, EBO John… - International journal of …, 2019 - mdpi.com
Intrinsically disordered proteins (IDPs) do not have rigid 3D structures, showing changes in
their folding depending on the environment or ligands. Intrinsically disordered proteins are …